Hana Safah, MD
Professor of Clinical Medicine
Dr. Safah obtained her MD from the American University of Beirut in 1987. In 1991, she completed her residency training in Internal Medicine at Greater Baltimore Medical Center in Baltimore, MD. In 1994, she completed her fellowship training in Hematology and Medical Oncology at the University of Florida.
Dr. Safah joined the faculty of Tulane University School of Medicine in 1994 as an Instructor of Medicine. The following year she was promoted to an Assistant Professor of Medicine and Associate Medical Director of the Bone Marrow Transplant Program. In 2000, she was promoted to Associate Professor of Medicine and Director of the Bone Marrow Transplant Program. She has served as the Alternate Vice Chairperson of the TUHSC Committee on the Use of Human Subjects and the Medical Director of the Institutional Review Board. Dr. Safah is currently a Professor of Clinical Medicine and the Director of the Hematology and Medical Oncology Fellowship Program.
Dr. Safah serves on several committees at Tulane University including: Investigation Review Board, Institutional Review Board Committee on Use of Human Subjects, Critical Care Committee, and the Tulane University Promotions & Tenure Committee.
Dr. Safah is a member of the Louisiana State Medical Society, American Society of Hematology and the Advisory Board of the Program for Professional Values and Ethics in Medical Education. She is an active member of the civic community to include her membership on the Human Relation Committee for the city of New Orleans.
Dr. Safah’s areas of specialty include: Hematologic Malignancies, Bone Marrow Transplantation, Leukemia, Lymphoma, and Multiple Myeloma. Dr. Safah has published numerous articles and papers. In addition, she has conducted many clinical trials.
LaRussa VF, Safah H, Price S, miller A, Rozans M, Weiner R. Long-Term Culture System for Mesenchymal Colony Forming Cells (M-CFC). ISEH, Tutorial, New Orleans, LA, July 2004.
Zou L, Barnett B, Safah H, LaRussa V, Evdemon-Hogan M, Mottram P, Wei S, David O, Borvak J, Curiel T, Zou W. Bone Marrow is a Reservoir for CD4+CD25+ Regulatory T Cells That Traffick Through CXCL12/CXCR4 Signals. Cancer Research; November 2004.
LaRussa VF, Price S, Miller A, Safah H, Rozans M, Weiner R: Engraftment and Long-Term production of mesenchymal colony forming cells in vitro. Exp Hematol, Paris 2003.
Guanchao J, Yang F, Li M, Weissbecker K, Price S, Kim K.C., LaRussa V, Safah H, Ehrlich M. Imatinib (ST1571) Provides Only Limited Selectivity for CML Cells and Treatment Might Be Complicated by Silent BCR-ABL Genes. Cancer Biology & Therapy January/February 2003; 2(1):166/1-166/7.
LaRussa, V, Miller A, Mondal D, Rozans M, Safah H, Curiel T, Agrawal K, Weiner R. Neuronal Stem Cells Biology and Plasticity. Cancer Investigation 2003; 21(5):792-804.
Briggs A, Safah H, List A, Epner E, Weiner R, Rink J, Miller A. Immunoablative transplantation for lymphoid malignancies. November 2001.
Jiang G, Yang F, Price S, LaRussa V, Safah H, Ehrlich M. ST1571 Treatment in vitro preferentially inhibits the formation of hematopoietic precursor-derived colonies that display BCR-ABL RNA and ABL Pa promoter methylation. November 2001.
Sun B, Jiang G, Zaydin M, LaRussa V, Safah H, Ehrlich M. ABL1 Promoter Methylation Exist Independently of BCR-ABL Transcription In Chronic Myeloid Leukemia Hematopoietic Progenitors. Cancer Research 2001, Sept. 15; pp. 6931-6937.
Miller AM, Morrison D, Safah H, Cullins S, LaRussa V, Rink J and Weiner RS. Decreased Quality of Peripheral Blood Progenitors Collected After A Peripheral Blood Progenitor Transplant. Journal of Hematotherapy in Stem Cell Research 2000; 9:475-480.
1430 Tulane Ave, New Orleans, LA 70112 504-988-5187 email@example.com